Shopping Cart
- Remove All
Your shopping cart is currently empty
Salmeterol (GR33343X) is a long-acting agonist of beta2-adrenergic receptor (beta 2AR) used for treatment ofasthma.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $50 | In Stock | |
| 10 mg | $80 | In Stock | |
| 25 mg | $156 | In Stock | |
| 50 mg | $288 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $70 | In Stock |
| Description | Salmeterol (GR33343X) is a long-acting agonist of beta2-adrenergic receptor (beta 2AR) used for treatment ofasthma. |
| Targets&IC50 | β1-adrenoceptor:6.1 (pEC50), β3-adrenoceptor:5.9 (pEC50), β2-adrenoceptor:9.6 (pEC50) |
| Synonyms | GR33343X |
| Molecular Weight | 415.57 |
| Formula | C25H37NO4 |
| Cas No. | 89365-50-4 |
| Smiles | OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1 |
| Relative Density. | 1.112 g/cm3 (Predicted) |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (240.63 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (9.63 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.